The 2021 Dr Theo George Wilson Annual Lecture was be given by Professor Teresa Lambe OBE. Professor Teresa Lambe is a Principal Investigator/Group leader based at the Jenner Institute at the University of Oxford. She has been at the forefront of the development of the Oxford–AstraZeneca COVID-19 vaccine.
After the annual lecture there was an intimate “online fireside discussion” with Professor Teresa Lambe and a few other Imperial experts.
To view a recording of this event please click below.
About the speaker
Teresa Lambe OBE is a Principal Investigator/Group leader based at the Jenner Institute. She is one of the co-developers of the Oxford–AstraZeneca COVID-19 vaccine against the new coronavirus causing COVID-19.
Prof Lambe’s research investigates the establishment of protective immune responses following vaccination and the formation of adaptive immune memory. She is particularly interested in delineating the immune response post vaccination and also post natural infection to help develop vaccines and define correlates of protection. At the University of Oxford, her group uses platform technologies to develop vaccines against emerging and re-emerging pathogens. The group is currently developing vaccines against a number of outbreak pathogens including Crimean-Congo haemorrhagic fever virus, Lassa virus, Nipah virus, Influenza, Ebolavirus and coronaviruses.
Online Fireside Discussion Participants
Professor James Moore Jr ,The Bagrit & RAEng Chair in Medical Device Design, Department of Bioengineering, Imperial College London. Dr. Moore’s research interests include Cardiovascular Biomechanics, Stents, Implantable Devices, Atherosclerosis, and the Lymphatic System. His research focuses on the role of biomechanics in the formation and treatment of diseases such as atherosclerosis and cancer.
Dr. Zoltán Kis, Lecturer at the Department of Chemical and Biological Engineering at The University of Sheffield. Zoltán is developing and modelling rapid-response vaccine production platform technologies, such as the RNA platform. This work is addressing the challenge of producing large volumes of vaccines, rapidly, at high quality and at low cost for pandemic-response.
Dr. Maria Papathanasiou, Lecturer in the Department of Chemical Engineering Imperial College London. Dr. Maria Papathanasiou's lab focuses on the adaptation of Industry 4.0 principles in (bio-) pharmaceutical processes. They work on the development of digital twins and control methodologies for process understanding, optimisation and automation.
Previous Annual Lectures
Making a Material Difference to Green Energy (Batteries Included) - 2020
To watch the annual lecture please click on the link in the title above.
The development and deeper understanding of new materials are critical to enable the next-generation of clean energy technologies. This talk highlights the use of advanced modelling methods in synergy with experimental work to gain atomic-scale insights into novel materials for lithium batteries and perovskite solar cells.
About the speaker
Saiful is Professor of Materials Chemistry at the University of Bath, having previously completed a Chemistry degree and PhD at University College London, a postdoctoral fellowship on oxide superconductors at the Eastman Kodak Labs in Rochester, New York, USA, and a lectureship at the University of Surrey. His research interests include computer modelling of new materials for lithium and sodium batteries, solid oxide fuel cells and perovskite solar cells.
Saiful’s research is supported by the EPSRC, and he has received several awards including the Wolfson Research Merit Award from the Royal Society and the Sustainable Energy Award from the Royal Society of Chemistry. He has presented more than 80 invited talks at international conferences, has around 220 publications and gave the Royal Institution Christmas Lectures in 2016 for BBC TV.
He sits on the Public Engagement Committee of the Royal Society and is a Patron of Humanists UK.
Science and technology challenges in modern drug discovery and development - 2019
Tony Wood, Senior Vice President, Medicinal Science & Technology, GSK gave the inaugural IMSE Annual Lecture.